✦ LIBER ✦

Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants

✍ Scribed by J. YOUNG

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development of Motavizumab, an Ultra-pot

✍ Herren Wu; David S. Pfarr; Syd Johnson; Yambasu A. Brewah; Robert M. Woods; Nita 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 1023 KB

Acute lower respiratory tract infections

✍ Lone Graff Stensballe; Ernesto Nante; Inge Panum Jensen; Poul-Erik Kofoed; Anja 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Viral agents causing lower respiratory t

✍ W. Sánchez-Yebra; J. A. Ávila-Carrillo; F. Giménez-Sánchez; A. Reyes-Bertos; M. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 195 KB

Incidence of Respiratory Syncytial Virus

✍ G. A. Rossi; M. C. Medici; R. Merolla 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 346 KB

Optimizing the delivery and use of a new

✍ Andrew Warren; Joanne M. Langley; Wanda Thomas; Jeff Scott 📂 Article 📅 2007 🏛 Pulsus Group Inc 🌐 English ⚖ 251 KB

Development of a real time reverse trans

✍ Kim Willoughby; Karen Thomson; Madeleine Maley; Janice Gilray; Sandra Scholes; F 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 258 KB